A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
Clinical trial NCT06565650 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06565650
- Sponsor
- Bausch & Lomb Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-11-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.